 | • レポートコード：QAF27941 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のVRE・MRSA抗生物質市場について種類別（バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他）、用途別（病院、診療所、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・VRE・MRSA抗生物質市場の概要 ・世界の主要地域別VRE・MRSA抗生物質市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のVRE・MRSA抗生物質市場規模2016-2021：種類別（バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他） ・世界のVRE・MRSA抗生物質市場予測2012-2027：種類別（バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他） ・世界のVRE・MRSA抗生物質市場規模2016-2021：用途別（病院、診療所、その他） ・世界のVRE・MRSA抗生物質市場予測2012-2027：用途別（病院、診療所、その他） ・VRE・MRSA抗生物質のアメリカ市場規模と予測2016-2021 ・VRE・MRSA抗生物質のヨーロッパ市場規模と予測2016-2021 ・VRE・MRSA抗生物質の中国市場規模と予測2016-2021 ・VRE・MRSA抗生物質の日本市場規模と予測2016-2021 ・VRE・MRSA抗生物質の東南アジア市場規模と予測2016-2021 ・VRE・MRSA抗生物質のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Lilly、Sanofi Aventis、Merck、Fresenius Kabi、Xellia Pharmaceuticals (Novo Holdings)、Zhejiang Medicine、Zhejiang Hisun Pharmaceutical、North China Pharmaceutical、Korea United Pharm） ・VRE・MRSA抗生物質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・VRE・MRSA抗生物質の市場動向・機会・課題 ・調査の結論 |
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause serious infections. MRSA can be spread by touching articles that have been contaminated by the skin of an infected or colonized person, such as towels, sheets, and wound dressings; VRE can be transmitted by touching articles soiled by an infected person’s feces. Both of these bacteria survive well on hands and for weeks on inanimate objects. Colonization occurs when bacteria are present on or in the body (i.e., nose, skin, rectum, moist areas of the body and the newborn’s umbilicus) without causing illness.
An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria.
The market for is VRE and MRSA Antibiotic market fragmented with players such as Pfizer, Lilly, Sanofi Aventis, Merck, Fresenius Kabi, Xellia Pharmaceuticals (Novo Holdings), Zhejiang Medicine, Zhejiang Hisun Pharmaceutical, North China Pharmaceutical. Among the companies, pfizer contributed 16% of the market, which is the biggest in 2019.
Category, included in this market are Teicoplanin, Vancomycin, Linezolid, Daptomycin, Others. The Linezolid contributed most in the revenue of the VRE and MRSA Antibiotic，which is 38% of the market.
The application for VRE and MRSA Antibiotic market is segment with application such as hospitals, clinics and others, in 2020, the sales in the hospitals is the biggest, occupies almost 2/3 of the market.
As for the regional market share, the Americas is expected to hold the largest share of the global MRSA drugs market.
Market Analysis and Insights: Global VRE and MRSA Antibiotic Market
The global VRE and MRSA Antibiotic market was valued at US$ 4075.8 in 2020 and will reach US$ 5369 million by the end of 2027, growing at a CAGR of 4.7% during 2022-2027.
Global VRE and MRSA Antibiotic Scope and Market Size
The global VRE and MRSA Antibiotic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global VRE and MRSA Antibiotic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Vancomycin
Teicoplanin
Linezolid
Daptomycin
Others
Segment by Application
Hospitals
Clinics
Others
The VRE and MRSA Antibiotic market is analysed and market size information is provided by regions (countries). Segment by Application, the VRE and MRSA Antibiotic market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
Lilly
Sanofi Aventis
Merck
Fresenius Kabi
Xellia Pharmaceuticals (Novo Holdings)
Zhejiang Medicine
Zhejiang Hisun Pharmaceutical
North China Pharmaceutical
Korea United Pharm
1 VRE and MRSA Antibiotic Market Overview
1.1 VRE and MRSA Antibiotic Product Scope
1.2 VRE and MRSA Antibiotic Segment by Type
1.2.1 Global VRE and MRSA Antibiotic Sales by Type (2016 & 2021 & 2027)
1.2.2 Vancomycin
1.2.3 Teicoplanin
1.2.4 Linezolid
1.2.5 Daptomycin
1.2.6 Others
1.3 VRE and MRSA Antibiotic Segment by Application
1.3.1 Global VRE and MRSA Antibiotic Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 VRE and MRSA Antibiotic Market Estimates and Forecasts (2016-2027)
1.4.1 Global VRE and MRSA Antibiotic Market Size in Value Growth Rate (2016-2027)
1.4.2 Global VRE and MRSA Antibiotic Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global VRE and MRSA Antibiotic Price Trends (2016-2027)
2 VRE and MRSA Antibiotic Estimates and Forecasts by Region
2.1 Global VRE and MRSA Antibiotic Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global VRE and MRSA Antibiotic Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global VRE and MRSA Antibiotic Sales Market Share by Region (2016-2021)
2.2.2 Global VRE and MRSA Antibiotic Revenue Market Share by Region (2016-2021)
2.3 Global VRE and MRSA Antibiotic Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global VRE and MRSA Antibiotic Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global VRE and MRSA Antibiotic Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
2.4.2 Europe VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
2.4.3 China VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
2.4.4 Japan VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
2.4.5 Southeast Asia VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
2.4.6 India VRE and MRSA Antibiotic Estimates and Projections (2016-2027)
3 Global VRE and MRSA Antibiotic Competition Landscape by Players
3.1 Global Top VRE and MRSA Antibiotic Players by Sales (2016-2021)
3.2 Global Top VRE and MRSA Antibiotic Players by Revenue (2016-2021)
3.3 Global VRE and MRSA Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in VRE and MRSA Antibiotic as of 2020)
3.4 Global VRE and MRSA Antibiotic Average Price by Company (2016-2021)
3.5 Manufacturers VRE and MRSA Antibiotic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global VRE and MRSA Antibiotic Market Size by Type
4.1 Global VRE and MRSA Antibiotic Historic Market Review by Type (2016-2021)
4.1.1 Global VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
4.1.2 Global VRE and MRSA Antibiotic Revenue Market Share by Type (2016-2021)
4.1.3 Global VRE and MRSA Antibiotic Price by Type (2016-2021)
4.2 Global VRE and MRSA Antibiotic Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global VRE and MRSA Antibiotic Sales Forecast by Type (2022-2027)
4.2.2 Global VRE and MRSA Antibiotic Revenue Forecast by Type (2022-2027)
4.2.3 Global VRE and MRSA Antibiotic Price Forecast by Type (2022-2027)
5 Global VRE and MRSA Antibiotic Market Size by Application
5.1 Global VRE and MRSA Antibiotic Historic Market Review by Application (2016-2021)
5.1.1 Global VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
5.1.2 Global VRE and MRSA Antibiotic Revenue Market Share by Application (2016-2021)
5.1.3 Global VRE and MRSA Antibiotic Price by Application (2016-2021)
5.2 Global VRE and MRSA Antibiotic Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global VRE and MRSA Antibiotic Sales Forecast by Application (2022-2027)
5.2.2 Global VRE and MRSA Antibiotic Revenue Forecast by Application (2022-2027)
5.2.3 Global VRE and MRSA Antibiotic Price Forecast by Application (2022-2027)
6 North America VRE and MRSA Antibiotic Market Facts & Figures
6.1 North America VRE and MRSA Antibiotic Sales by Company
6.1.1 North America VRE and MRSA Antibiotic Sales by Company (2016-2021)
6.1.2 North America VRE and MRSA Antibiotic Revenue by Company (2016-2021)
6.2 North America VRE and MRSA Antibiotic Sales Breakdown by Type
6.2.1 North America VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
6.2.2 North America VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
6.3 North America VRE and MRSA Antibiotic Sales Breakdown by Application
6.3.1 North America VRE and MRSA Antibiotic Sales Breakdown by Application (2016-2021)
6.3.2 North America VRE and MRSA Antibiotic Sales Breakdown by Application (2022-2027)
7 Europe VRE and MRSA Antibiotic Market Facts & Figures
7.1 Europe VRE and MRSA Antibiotic Sales by Company
7.1.1 Europe VRE and MRSA Antibiotic Sales by Company (2016-2021)
7.1.2 Europe VRE and MRSA Antibiotic Revenue by Company (2016-2021)
7.2 Europe VRE and MRSA Antibiotic Sales Breakdown by Type
7.2.1 Europe VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
7.2.2 Europe VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
7.3 Europe VRE and MRSA Antibiotic Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)
8 China VRE and MRSA Antibiotic Market Facts & Figures
8.1 China VRE and MRSA Antibiotic Sales by Company
8.1.1 China VRE and MRSA Antibiotic Sales by Company (2016-2021)
8.1.2 China VRE and MRSA Antibiotic Revenue by Company (2016-2021)
8.2 China VRE and MRSA Antibiotic Sales Breakdown by Type
8.2.1 China VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
8.2.2 China VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
8.3 China VRE and MRSA Antibiotic Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan VRE and MRSA Antibiotic Market Facts & Figures
9.1 Japan VRE and MRSA Antibiotic Sales by Company
9.1.1 Japan VRE and MRSA Antibiotic Sales by Company (2016-2021)
9.1.2 Japan VRE and MRSA Antibiotic Revenue by Company (2016-2021)
9.2 Japan VRE and MRSA Antibiotic Sales Breakdown by Type
9.2.1 Japan VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
9.2.2 Japan VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
9.3 Japan VRE and MRSA Antibiotic Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia VRE and MRSA Antibiotic Market Facts & Figures
10.1 Southeast Asia VRE and MRSA Antibiotic Sales by Company
10.1.1 Southeast Asia VRE and MRSA Antibiotic Sales by Company (2016-2021)
10.1.2 Southeast Asia VRE and MRSA Antibiotic Revenue by Company (2016-2021)
10.2 Southeast Asia VRE and MRSA Antibiotic Sales Breakdown by Type
10.2.1 Southeast Asia VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia VRE and MRSA Antibiotic Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India VRE and MRSA Antibiotic Market Facts & Figures
11.1 India VRE and MRSA Antibiotic Sales by Company
11.1.1 India VRE and MRSA Antibiotic Sales by Company (2016-2021)
11.1.2 India VRE and MRSA Antibiotic Revenue by Company (2016-2021)
11.2 India VRE and MRSA Antibiotic Sales Breakdown by Type
11.2.1 India VRE and MRSA Antibiotic Sales Breakdown by Type (2016-2021)
11.2.2 India VRE and MRSA Antibiotic Sales Breakdown by Type (2022-2027)
11.3 India VRE and MRSA Antibiotic Sales Breakdown by Application
11.3.1 India VRE and MRSA Antibiotic Sales Breakdown by Application (2016-2021)
11.3.2 India VRE and MRSA Antibiotic Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in VRE and MRSA Antibiotic Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer VRE and MRSA Antibiotic Products Offered
12.1.5 Pfizer Recent Development
12.2 Lilly
12.2.1 Lilly Corporation Information
12.2.2 Lilly Business Overview
12.2.3 Lilly VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Lilly VRE and MRSA Antibiotic Products Offered
12.2.5 Lilly Recent Development
12.3 Sanofi Aventis
12.3.1 Sanofi Aventis Corporation Information
12.3.2 Sanofi Aventis Business Overview
12.3.3 Sanofi Aventis VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Aventis VRE and MRSA Antibiotic Products Offered
12.3.5 Sanofi Aventis Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck VRE and MRSA Antibiotic Products Offered
12.4.5 Merck Recent Development
12.5 Fresenius Kabi
12.5.1 Fresenius Kabi Corporation Information
12.5.2 Fresenius Kabi Business Overview
12.5.3 Fresenius Kabi VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi VRE and MRSA Antibiotic Products Offered
12.5.5 Fresenius Kabi Recent Development
12.6 Xellia Pharmaceuticals (Novo Holdings)
12.6.1 Xellia Pharmaceuticals (Novo Holdings) Corporation Information
12.6.2 Xellia Pharmaceuticals (Novo Holdings) Business Overview
12.6.3 Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Products Offered
12.6.5 Xellia Pharmaceuticals (Novo Holdings) Recent Development
12.7 Zhejiang Medicine
12.7.1 Zhejiang Medicine Corporation Information
12.7.2 Zhejiang Medicine Business Overview
12.7.3 Zhejiang Medicine VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zhejiang Medicine VRE and MRSA Antibiotic Products Offered
12.7.5 Zhejiang Medicine Recent Development
12.8 Zhejiang Hisun Pharmaceutical
12.8.1 Zhejiang Hisun Pharmaceutical Corporation Information
12.8.2 Zhejiang Hisun Pharmaceutical Business Overview
12.8.3 Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Products Offered
12.8.5 Zhejiang Hisun Pharmaceutical Recent Development
12.9 North China Pharmaceutical
12.9.1 North China Pharmaceutical Corporation Information
12.9.2 North China Pharmaceutical Business Overview
12.9.3 North China Pharmaceutical VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 North China Pharmaceutical VRE and MRSA Antibiotic Products Offered
12.9.5 North China Pharmaceutical Recent Development
12.10 Korea United Pharm
12.10.1 Korea United Pharm Corporation Information
12.10.2 Korea United Pharm Business Overview
12.10.3 Korea United Pharm VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Korea United Pharm VRE and MRSA Antibiotic Products Offered
12.10.5 Korea United Pharm Recent Development
13 VRE and MRSA Antibiotic Manufacturing Cost Analysis
13.1 VRE and MRSA Antibiotic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of VRE and MRSA Antibiotic
13.4 VRE and MRSA Antibiotic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 VRE and MRSA Antibiotic Distributors List
14.3 VRE and MRSA Antibiotic Customers
15 Market Dynamics
15.1 VRE and MRSA Antibiotic Market Trends
15.2 VRE and MRSA Antibiotic Drivers
15.3 VRE and MRSA Antibiotic Market Challenges
15.4 VRE and MRSA Antibiotic Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global VRE and MRSA Antibiotic Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global VRE and MRSA Antibiotic Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global VRE and MRSA Antibiotic Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global VRE and MRSA Antibiotic Sales (M Units) by Region (2016-2021)
Table 5. Global VRE and MRSA Antibiotic Sales Market Share by Region (2016-2021)
Table 6. Global VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global VRE and MRSA Antibiotic Revenue Share by Region (2016-2021)
Table 8. Global VRE and MRSA Antibiotic Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global VRE and MRSA Antibiotic Sales Market Share Forecast by Region (2022-2027)
Table 10. Global VRE and MRSA Antibiotic Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global VRE and MRSA Antibiotic Revenue Share Forecast by Region (2022-2027)
Table 12. Global VRE and MRSA Antibiotic Sales (M Units) of Key Companies (2016-2021)
Table 13. Global VRE and MRSA Antibiotic Sales Share by Company (2016-2021)
Table 14. Global VRE and MRSA Antibiotic Revenue (US$ Million) by Company (2016-2021)
Table 15. Global VRE and MRSA Antibiotic Revenue Share by Company (2016-2021)
Table 16. Global VRE and MRSA Antibiotic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in VRE and MRSA Antibiotic as of 2020)
Table 17. Global VRE and MRSA Antibiotic Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers VRE and MRSA Antibiotic Manufacturing Sites and Area Served
Table 19. Manufacturers VRE and MRSA Antibiotic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global VRE and MRSA Antibiotic Sales (M Units) by Type (2016-2021)
Table 22. Global VRE and MRSA Antibiotic Sales Share by Type (2016-2021)
Table 23. Global VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global VRE and MRSA Antibiotic Price (USD/Unit) by Type (2016-2021)
Table 25. Global VRE and MRSA Antibiotic Sales Share by Type (2022-2027)
Table 26. Global VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global VRE and MRSA Antibiotic Revenue Share by Type (2022-2027)
Table 28. Global VRE and MRSA Antibiotic Price (USD/Unit) by Type (2022-2027)
Table 29. Global VRE and MRSA Antibiotic Sales (M Units) by Application (2016-2021)
Table 30. Global VRE and MRSA Antibiotic Sales Share by Application (2016-2021)
Table 31. Global VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global VRE and MRSA Antibiotic Price (USD/Unit) by Application (2016-2021)
Table 33. Global VRE and MRSA Antibiotic Sales (M Units) by Application (2022-2027)
Table 34. Global VRE and MRSA Antibiotic Sales Share by Application (2022-2027)
Table 35. Global VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global VRE and MRSA Antibiotic Revenue Share by Application (2022-2027)
Table 37. Global VRE and MRSA Antibiotic Price (USD/Unit) by Application (2022-2027)
Table 38. North America VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 39. North America VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 40. North America VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 42. North America VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 43. North America VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 44. North America VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 45. North America VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 46. North America VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 47. North America VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 48. North America VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 49. North America VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 50. Europe VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 51. Europe VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 52. Europe VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 54. Europe VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 55. Europe VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 56. Europe VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 57. Europe VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 58. Europe VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 59. Europe VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 60. Europe VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 61. Europe VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 62. China VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 63. China VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 64. China VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 65. China VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 66. China VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 67. China VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 68. China VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 69. China VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 70. China VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 71. China VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 72. China VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 73. China VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 74. Japan VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 75. Japan VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 76. Japan VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 78. Japan VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 79. Japan VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 80. Japan VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 81. Japan VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 82. Japan VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 83. Japan VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 84. Japan VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 85. Japan VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 98. India VRE and MRSA Antibiotic Sales (M Units) by Company (2016-2021)
Table 99. India VRE and MRSA Antibiotic Sales Market Share by Company (2016-2021)
Table 100. India VRE and MRSA Antibiotic Revenue by Company (2016-2021) & (US$ Million)
Table 101. India VRE and MRSA Antibiotic Revenue Market Share by Company (2016-2021)
Table 102. India VRE and MRSA Antibiotic Sales by Type (2016-2021) & (M Units)
Table 103. India VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Table 104. India VRE and MRSA Antibiotic Sales by Type (2022-2027) & (M Units)
Table 105. India VRE and MRSA Antibiotic Sales Market Share by Type (2022-2027)
Table 106. India VRE and MRSA Antibiotic Sales by Application (2016-2021) & (M Units)
Table 107. India VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Table 108. India VRE and MRSA Antibiotic Sales by Application (2022-2027) & (M Units)
Table 109. India VRE and MRSA Antibiotic Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer VRE and MRSA Antibiotic Product
Table 114. Pfizer Recent Development
Table 115. Lilly Corporation Information
Table 116. Lilly Description and Business Overview
Table 117. Lilly VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Lilly VRE and MRSA Antibiotic Product
Table 119. Lilly Recent Development
Table 120. Sanofi Aventis Corporation Information
Table 121. Sanofi Aventis Description and Business Overview
Table 122. Sanofi Aventis VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi Aventis VRE and MRSA Antibiotic Product
Table 124. Sanofi Aventis Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck VRE and MRSA Antibiotic Product
Table 129. Merck Recent Development
Table 130. Fresenius Kabi Corporation Information
Table 131. Fresenius Kabi Description and Business Overview
Table 132. Fresenius Kabi VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Fresenius Kabi VRE and MRSA Antibiotic Product
Table 134. Fresenius Kabi Recent Development
Table 135. Xellia Pharmaceuticals (Novo Holdings) Corporation Information
Table 136. Xellia Pharmaceuticals (Novo Holdings) Description and Business Overview
Table 137. Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Product
Table 139. Xellia Pharmaceuticals (Novo Holdings) Recent Development
Table 140. Zhejiang Medicine Corporation Information
Table 141. Zhejiang Medicine Description and Business Overview
Table 142. Zhejiang Medicine VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Zhejiang Medicine VRE and MRSA Antibiotic Product
Table 144. Zhejiang Medicine Recent Development
Table 145. Zhejiang Hisun Pharmaceutical Corporation Information
Table 146. Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 148. Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Product
Table 149. Zhejiang Hisun Pharmaceutical Recent Development
Table 150. North China Pharmaceutical Corporation Information
Table 151. North China Pharmaceutical VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. North China Pharmaceutical Description and Business Overview
Table 153. North China Pharmaceutical VRE and MRSA Antibiotic Product
Table 154. North China Pharmaceutical Recent Development
Table 155. Korea United Pharm Corporation Information
Table 156. Korea United Pharm Description and Business Overview
Table 157. Korea United Pharm VRE and MRSA Antibiotic Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Korea United Pharm VRE and MRSA Antibiotic Product
Table 159. Korea United Pharm Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. VRE and MRSA Antibiotic Distributors List
Table 163. VRE and MRSA Antibiotic Customers List
Table 164. VRE and MRSA Antibiotic Market Trends
Table 165. VRE and MRSA Antibiotic Market Drivers
Table 166. VRE and MRSA Antibiotic Market Challenges
Table 167. VRE and MRSA Antibiotic Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. VRE and MRSA Antibiotic Product Picture
Figure 2. Global VRE and MRSA Antibiotic Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global VRE and MRSA Antibiotic Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global VRE and MRSA Antibiotic Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global VRE and MRSA Antibiotic Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global VRE and MRSA Antibiotic Sales (M Units) Growth Rate (2016-2027)
Figure 12. Global VRE and MRSA Antibiotic Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global VRE and MRSA Antibiotic Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global VRE and MRSA Antibiotic Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America VRE and MRSA Antibiotic Sales (M Units) Growth Rate (2016-2027)
Figure 17. Europe VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe VRE and MRSA Antibiotic Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China VRE and MRSA Antibiotic Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan VRE and MRSA Antibiotic Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia VRE and MRSA Antibiotic Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India VRE and MRSA Antibiotic Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India VRE and MRSA Antibiotic Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest VRE and MRSA Antibiotic Players Market Share by Revenue in VRE and MRSA Antibiotic: 2016 & 2020
Figure 28. VRE and MRSA Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global VRE and MRSA Antibiotic Revenue Share by Type (2016-2021)
Figure 30. Global VRE and MRSA Antibiotic Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global VRE and MRSA Antibiotic Revenue Share by Application (2016-2021)
Figure 32. Global VRE and MRSA Antibiotic Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 34. North America VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 35. Europe VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 36. Europe VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 37. China VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 38. China VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 39. Japan VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 40. Japan VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 41. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 42. Southeast Asia VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 43. India VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 44. India VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of VRE and MRSA Antibiotic
Figure 47. Manufacturing Process Analysis of VRE and MRSA Antibiotic
Figure 48. VRE and MRSA Antibiotic Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の抗生物質感受性試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antibiotic Sensitivity Testing Market The global Antibiotic Sensitivity Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界のバンコマイシン耐性腸球菌フェシウム治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
- 世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Diseases In Vitro Diagnostics Market The global Infectious Diseases In Vitro Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界のポイントオブケア感染症市場規模・現状・予測（2021年-2027年） A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management. Market Analysis and Insights: Global Point…
- 結膜炎のグローバル市場2021 Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications. The techn…